The Hindu Business Line : Monday, July 28, 2008

MARKETS

RECOMMENDATION: Aventis Pharma (Rs 775.15): Buy
We recommend a buy in Aventis Pharma from a short-term perspective. We note that this stock has been on a very long-term downtrend from its May 2006 high of Rs 2,125. However, the stock found support at around Rs 700 in early July 2008 ...

RECOMMENDATION: Day Trading Guide
The analysis and opinion expressed in these columns are based on the technical analysis of the past price behaviour. The stop-loss level provided with the recommendation is important. The original view would stand negated if the stop-loss ...

STOCKS: Winning the trust vote makes Govt richer by Rs 64,000 cr in M-cap
BL Research Bureau The recent political tussle, which ended with the incumbent government winning the Trust vote on July 22, has left the Union Government richer by Rs 86,600 crore, at least on paper. ...

OUTLOOK: Equity market may remain volatile this week
Positive bias may surface as ‘sell’ is replaced by ‘hold’ strategies. When on July 22 Dr Manmohan Singh’s UPA Government won the trust vote, there was an overhang of shorts about Rs 13,000 crore by the foreign ...

MUTUAL FUNDS: Making mutual funds to fund your investment
Growth, dividend options offer long-term appreciation, regular income. Coimbatore, July 27 Mutual funds have put up a strong show in the backdrop of the bull run witnessed in the equity markets in the last five years. ...

FOREIGN INSTITUTIONAL INVESTORS: Capital gains tax
That is a good question. FIIs have been ducking taxation thanks largely to the Indo-Mauritius tax treaty which vests the latter with the power to impose capital gains tax on gains made in the Indian bourses. But ironically there is no capital ...

COMMENTARY: MTNL, the star performer
The US markets were volatilelifted by lower crude oil prices and hints of an economic rebound on the one hand, but were tempered on fears of recovery. The Dow Jones Industrial Average slumped by 1.09 per cent last week, while the broad-market ...